Dextroamphetamine

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

31 API Suppliers, 22 USDMF, 3 CEP/COS, 17 NDC API, 13 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

58 Drugs in Development

58 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

509 FDF Dossiers, 429 FDA Orange Book, 39 Europe, 6 Canada, 1 Australia, 3 South Africa, 31 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE, EXTENDED RELEASE;ORAL - 10MG, CAPSULE, EXTENDED RELEASE;ORAL - 15MG, CAPSULE, EXTENDED RELEASE;ORAL - 5MG, SUSPENSION, EXTENDED RELEASE;ORAL - EQ 1.25MG BASE/ML, TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL - EQ 12.5MG BASE, TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL - EQ 15.7MG BASE, TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL - EQ 18.8MG BASE, TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL - EQ 3.1MG BASE, TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL - EQ 6.3MG BASE, TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL - EQ 9.4MG BASE, SUSPENSION, EXTENDED RELEASE;ORAL - 2MG/ML;EQ 0.5MG BASE/ML, TABLET, EXTENDED RELEASE;ORAL - 12MG;EQ 3MG BASE, TABLET, EXTENDED RELEASE;ORAL - 16MG;EQ 4MG BASE, TABLET, EXTENDED RELEASE;ORAL - 4MG;EQ 1MG BASE, TABLET, EXTENDED RELEASE;ORAL - 8MG;EQ 2MG BASE, CAPSULE, EXTENDED RELEASE;ORAL - 1.25MG;1.25MG;1.25MG;1.25MG, CAPSULE, EXTENDED RELEASE;ORAL - 2.5MG;2.5MG;2.5MG;2.5MG, CAPSULE, EXTENDED RELEASE;ORAL - 3.75MG;3.75MG;3.75MG;3.75MG, CAPSULE, EXTENDED RELEASE;ORAL - 5MG;5MG;5MG;5MG, CAPSULE, EXTENDED RELEASE;ORAL - 6.25MG;6.25MG;6.25MG;6.25MG, CAPSULE, EXTENDED RELEASE;ORAL - 7.5MG;7.5MG;7.5MG;7.5MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 9 Evonik, 6 Rochem International Inc, 19 SPI Pharma, 13 DKSH, 2 Pharm-RX Chemical, 5 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 4 Kirsch Pharma, 4 ACG Worldwide, 10 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 35 BASF, 1 Bioplus Life Sciences, 2 CD Formulation, 21 Corel Pharma Chem, 5 DFE Pharma, 3 Doshion Polyscience, 1 Esteem Industries, 2 Finar, 12 Gangwal Chemicals, 12 Ideal Cures, 4 Ingredion Pharma Solutions, 20 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 16 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 3 Novo Excipients, 4 Pharmatrans-Sanaq, 8 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 33 Roquette, 14 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 3 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 2 Valens Pharmachem, 3 Vasa Pharmachem, 1 Vertellus, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

80 Fillers, Diluents & Binders, 66 Coating Systems & Additives, 45 Controlled & Modified Release, 40 Thickeners and Stabilizers, 39 Direct Compression, 37 Solubilizers, 36 Taste Masking, 34 Disintegrants & Superdisintegrants, 33 Granulation, 23 Parenteral, 23 Film Formers & Plasticizers, 21 Chewable & Orodispersible Aids, 20 Topical, 18 Lubricants & Glidants, 13 Co-Processed Excipients, 10 Emulsifying Agents, 9 Empty Capsules, 8 Rheology Modifiers, 7 API Stability Enhancers, 5 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

DIGITAL CONTENT

110 News #PharmaBuzz

110 News #PharmaBuzz

GLOBAL SALES INFORMATION

58 US Medicaid Prescriptions, 27 Regulatory FDF Prices, 9 Annual Reports

MARKET PLACE

12 APIs, 1 Intermediates

PATENTS & EXCLUSIVITIES

102 US Patents, 4 US Exclusivities

REF. STANDARDS & IMPURITIES

8 Others

8 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 208147 / DOSAGE - SUSPENSION, EXTENDED RELEASE;ORAL - 2MG/ML;EQ 0.5MG BASE/ML

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
AMPHETAMINE(UNII: CK833KGX7E) (AMPHETAMINE - UNII:CK833KGX7E)	AMPHETAMINE	20mg \| 10mg \| 15mg \| 2.5mg in 1 \| 5mg

Inactive Ingredients

Ingredient Name	NextWave Pharmaceuticals, Inc
ANHYDROUS CITRIC ACID(XF417D3PSL)
CROSPOVIDONE(2S7830E561)
GLYCERIN(PDC6A3C0OX)
GUAR GUM(E89I1637KE)
MAGNESIUM STEARATE(70097M6I30)
MANNITOL(3OWL53L36A)
METHYLPARABEN(A2I8C7HI9T)
MICROCRYSTALLINE CELLULOSE(OP1R32D61U)
MODIFIED CORN STARCH (1-OCTENYL SUCCINIC ANHYDRIDE)(461P5CJN6T)
POLYSORBATE 80(6OZP39ZG8H)
POLYVINYL ACETATE(32K497ZK2U)
POVIDONE(FZ989GH94E)
PROPYLPARABEN(Z8IX2SC1OH)
SILICON DIOXIDE(ETJ7Z6XBU4)
SODIUM LAURYL SULFATE(368GB5141J)
SODIUM POLYSTYRENE SULFONATE(1699G8679Z)
SUCRALOSE(96K6UQ3ZD4)
TALC(7SEV7J4R1U)
TRIACETIN(XHX3C3X673)
XANTHAN GUM(TTV12P4NEE)

Setid Ae304b29 0b40 40ec Ad0d 76b742d4a9b9 Applno 208147 Form Suspension Extended Release Oral Dosage 2mg Ml Eq 0 5mg Base Ml - Drug Product Composition: Dextroamphetamine